Trial By Error: Another Letter Seeking Correction of Bogus “Clinically Effective” Claims from REGAIN Trial
By David Tuller, DrPH Last month, I sent a letter to Dr Abbasi, the editor-in-chief of The BMJ, about an egregious and arguably fraudulent claim in the REGAIN trial—an investigation of a Long Covid physical and mental health rehabilitation program. Several other experts co-signed the letter. The journal asked us to send in a rapid …